chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report was received from consumer, who is the patient's daughter on 13 January 2011. An 81 year-old female patient with a history of high cholesterol and a "heart patient with stents", had received an intramuscular injection of influenza vaccine (reported as FLUZONE, lot number and site of administration not reported) on 13 October 2010 and two days later on 15 October 2010, experienced "severe diarrhea" which lasted "two and a half months". According to the reporter everything the patient consumed "went right through her and she lost 20 pounds". concomitant medications included unspecified heart and cholesterol medications. The patient was not evaluated by a physician and treatments were not reported. No further information was available at the time of the report. The patient's outcome was reported as recovered. Follow-up information received from a health care professional on 23 February 2011 reported the patients' medical history included B12 deficiency, dysgeusia, hypertension (HTN) and coronary artery disease (CAD). The patients' concomitant medications included atenolol, CRESTOR, VICODIN prn and lorazepam prn. She had no reported illness at the time of vaccination. The FLUZONE lot number was reported as UH214AA and the injection was given in the left deltoid. The outcome remained recovered. Documents held by sender: none.
Event-Myalgia, fatigue,  fever, diaphoresis, nausea, chills, Rash/Pain at injection site Tx- Acetaminophen, Ibuprofen, Rest Time- 48 hours
Fever, nausea, vomit, chills, body aches, dizziness, sweats, left axially lymph node edema
Pt had a PREVNAR vaccine on 11/15/16 in her left arm and flu shot in her right arm. She had chills, and fatigue for 2 days after the injections. She feels better today, she has less fatigue and chills. She had less of an appetite. This is little bit better today. Her left upper arm started with a small amount of redness the day after she received the PREVNAR vaccine, then the redness spread down her left arm to just above her elbow yesterday. Dx with cellulitis, ordered for cephalexin 500 mg po tid x 10 days.
hives developed in the evening after first  vaccination, treated with otc oral benadryl.  Hives of scalp, neck, face and shoulders developed after the second vaccination on 5/19/2021, which was partially treated with otc oral benadryl.  The day following the 2nd vaccination, the patient developed nausea with vomiting, fever, sweats, shaking and chills for one day.
Information has been received from a physician's assistant (P.A.) concerning a approximately 3 month old patient who was vaccinated with a dose of ROTATEQ (lot # not reported) at the age of 6 weeks, in approximately Nov 2008. It was reported that the patient experienced intussusception "at 3 months of age", in approximately Jan 2009. Unspecified medical attention was sought. The baby had surgery and was hospitalized on 07-JAN-2009. As of 08-JAN-2009, the patient's outcome was unknown. Intussusception was considered to be an other important medical event by the reporter. Additional information has been requested.  2/17/09 MR received for DOS 1/7-10/2009 with D/C DX:  Intussusception.  Pt presented with 1 day hx of persistant nausea with bilious emesis, decreased UO, obstipation, lethargy and irritability. PE (+) for RLQ tenderness. IS noted on US.  Reduction attempted with air contrast enema, but unsucessful.  To OR for exploratory lap and reduction.  Bowel fxn returned 24 hrs post-op and diet advanced.  D/C home 1/10/09. .
Between two and three days after receiving the vaccine, my elbow started to swell with a little pain on the left side of my body...the same side as the vaccine. There was the huge sack of noticeable  fluid on my elbow which caused me problems in bending my arm. At the beginning of the week, I scheduled an appointment with my primary care office. I was told (after going to the computer) by the RA that is looked like bursitis and she could pop it.  Not trusting this person, I decided to go an orthopedic doctor that could give me more answers while not relying on the computer for info. He in turn said that I had an Enthesopathy (disorder)...bursitis. Quoted..."The cause of an enthesopathy may be mutltifactorial. There are inflammatory, degenerative, drug-induced, occupational, and infectious causes." I've never in my life had anything like this and only could recall it happening after the second vaccine to the same arm. After seeing my endocrinologist that same week, he in fact acknowledge that it could have been from the vaccine because of the inflammation he said that could go to any part of the body from the vaccine, In his case, it went to his hip. With NSAID, the suggested meds, I was able to elevate and ease the pain. Eventually it went away...Thank God!
Headache, Myalgia, loss of appetite, fatigue Narrative:  Other Relevant History:
I received a J&J vaccine in April, and got this one yesterday. Since we are all guinea pigs in this vast experiment, I wanted someone to know that I got 2 different vaccines in case they want to know and track what happens to me. Thank you.  No adverse affects noticed except a little muscle soreness at the injection site.
legs tickly from knee down; pain in bones and muscles; Every bone in body is hurting; chilling; pain in bones and muscles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic disease (unspecified).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles). At the time of the report, PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   No treatment medications provided by the reporter.
Very very slight itching and incredibly faint rash around injection site. Overall barely noticeable and very minor.
Diarrhea started day after vaccination on 12/30/21-05/2022 Endocort taper started at 9mg; currently taking 2mg
On 5/9/08, pt developed swelling from his belly button to his scrotum including his penis.  Evaluated at ER that day.  Instructed to monitor swelling.  Swelling resolved on 5/13/08.
Patient reported typically side effects the night of vaccination, chills and mild fever.  Patient took Acetaminophen the night of 3/6/2021.  On 3/7/2021 she stated that she woke up feeling fine.  While shopping on 3/7/2021 she had a syncopal episode in the grocery store and stated she passed out.  No injuries reported.  She left the store and stated that she felt very light headed again later in the day but did not pass out.
multiple episode of vomiting w/in 24 hrs of vax; also note possible day care exposure to varicella in the last wk; treatment clear liquids & home observation;
CHIEF COMPLAINT:   DX COVID + 6 days ago. Room air O2 80%. afebrile, Duo-neb x1, 10mg decadron IV. (-) COPD/asthma hx, (+) DM,   HISTORY OF PRESENT ILLNESS:     74-year-old woman past medical history of atrial fibrillation, coronary artery disease, CKD stage III, hypertension, diabetes, hyperlipidemia, obesity, hypothyroidism, osteoarthritis presents for shortness of breath with COVID-19.  Diagnosed with Covid 6 days ago.  Reports shortness of breath.  Per EMS satting 80% on room air.  Given 1 DuoNeb and 10 mg IV Decadron prior to arrival to ED.  No history of COPD.  No other modifying factors.  Symptoms are moderate in severity intensity and acute in duration.
This spontaneous report was received from a physician via a company representative concerning a 64 year old male patient. On 16-OCT-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date and dose unspecified), subcutaneously. No concomitant medications were reported. On 10-APR-2013, the patient was diagnosed with shingles during an office visit. The patient sought medical attention (office visit), It was unspecified if any treatment was provided or if any lab tests were performed. The outcome of shingles was unknown. The relatedness for shingles was unknown for ZOSTAVAX. Additional information has been requested.
Fever and chills on and off starting on Monday 12/28. Sore throat starting on Monday 12/28. Fatigue starting on 12/28. Continues to persist at this time.   Pfizer-bioNtech COVID-19 vaccine EUA
Supraclavicular lymph node is swollen and hard; This spontaneous case was reported by an other health care professional and describes the occurrence of LYMPHADENOPATHY (Supraclavicular lymph node is swollen and hard) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Supraclavicular lymph node is swollen and hard). At the time of the report, LYMPHADENOPATHY (Supraclavicular lymph node is swollen and hard) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant product was reported The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.   This case was linked to MOD-2021-034662 (Patient Link).
Patient received a dose of vaccine that was not reconstituted prior to administration. Patient reported fatigue, chills, fever, body aches and not feeling well at all on day 1 following administration of vaccine but is recovered now and just has a sore arm.
Report 20000121571 describes rash in a 29 year old female who received Engerix-B for prophylaxis of hep B. The vaccinee has no allergies. Her medical history was not specified. She takes oral contraceptives (NOS). There was no known illness at the time of vaccination. She received Engerix-B at age 6 with no adverse reaction. On 03/31/2000, the vaccinee received her first 1 cc IM deltoid dose of Engerix-B. 2-3 days later, she had a small rash (red spots) with itching. She took Benadryl over the weekend (April 1-2), and in addition was treated with cortisone tablets. As of 04/03/2000, she still had itching. As of 10/27/2000, the outcome of the events is resolved.
passed out several times; vertigo/dizzy; This is a spontaneous report from a contactable consumer (patient) from Pfizer-sponsored program. A 43-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on 12Feb2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date for COVID-19 immunization. The patient received the second dose on 12Feb2021 and woke up yesterday (15Feb2021) dizzy and passed out several times. The Dr diagnosed her with vertigo and gave medication for that (medication not named). The patient wanted to know if Pfizer COVID vaccine is linked with vertigo or not. This is her third time being transferred, she was clearly not feeling greatest and she has been on the phone for almost 30 minutes. The outcome of the events was unknown.  Information on the batch/lot number has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Sep2021 at 15:00 as dose 1, single (Batch/Lot number: unknown), in left arm and on 19Apr2022 at 16:00 as dose 2, single (Batch/Lot number: unknown) at the age of 72 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "uterine cancer" (unspecified if ongoing), notes: other medical history: Cancer/ chemo treatment ended 7, years for uterine cancer; "other medical history: Cancer/ chemo treatment" (unspecified if ongoing), notes: other medical history: Cancer/ chemo treatment ended 7, years for uterine cancer. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Patient received other medication in 2weeks product Over counter vitamins and Various brands on 01Jun2022 and 07Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
After patient was screened as eligible and J&J COVID vaccine administered, patient's family identified that patient had previously received 2 doses of Moderna on 4/15/21 and 5/14/21 from another healthcare system. This information was not present in state database when queried as part of screening process. It was later determined that patient has 2 profiles in the state system. Patient recovering from traumatic brain injury. No harm to patient identified from vaccine administration.
Noise in ear; prickly skin; blurred vision; fever; swollen mouth; "ball" swelling under arm; pain.  Patient visited doctor and was given antihistamine prescription to help with reaction.
Chief complaint of "feels like my heart is skipping a beat", palpitations, and some mild chest tightness. Intermittent shortness of breath. No fever or cough. No treatments were required, but cardiology recommended observation admission. No beds were available locally or state-wide. The patient opted to leave against the provider's advice and wished to follow up on an outpatient basis.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 23-OCT-2014, the patient was vaccinated with a dose of ZOSTAVAX, (lot number, expiry date was unknown). on 24-OCT-2014, the patient experienced red, scaly skin on both cheeks, widespread bodyaches and swelling at the injection site. On 26-OCT-2014, the patient went to the pharmacy to report the adverse effects. The patient spoke to her unspecified physician while in the pharmacy and the physician prescribed an unspecified topical hydrocortisone cream to be applied to the face. The outcome of the events were unknown. Additional information has been requested.
Right foot toe(next to big toe) turned bluish like a bruised toe. Showed Doctor she said that if it turned cold(which it hasn't) go to an emergency room. As of today 2/15/2021 it is still looking the same
Hives in his left arm and buttocks; Trouble breathing; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017821A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing). At the time of the report, URTICARIA (Hives in his left arm and buttocks) and DYSPNOEA (Trouble breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant product use was reported.  Treatment details included Benadryl and hydrocortisone 1% cream.
I started coughing a lot and I was running a low-grade fever. I was around some friends, and they contacted me to let me know one of them or more have tested positive for COVID-19. I took my temperature and then called my lung doctor, and we did a video chat appointment. The doctor decided to put me on PAXLOVID for 5 days and prednisone to take as needed if I was still coughing. Took the medication at prescribed and I am only currently on day 3-4. I feel like I am starting to improve not as much coughing but still some COVID-19 headache.
Patient is complaining of numbess in his Right Arm following ANT, TYV, and TPP immunizations on 14 Jun 2007; 5 days following immunizations.  Pt recieved Typhoid vaccine in Right Deltoid with IM injection, Anthrax in left deltoid with Sub-Q injection and PPD on right forearm.  The numbess is localized from his R Shoulder to his R Elbow with associated weakness upon a neuro exam.  Skin Color is Pink, Skin is Warm and Moist with Cap Refill < 3 Sec.  Individual has decreased muscle strength at shoulder with Full strength at Elbow.  At this time, Individual is being considered for Referral to Neurology evaluation.
fatigue; joint pain; temperature of 100.8; chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), FATIGUE (fatigue), ARTHRALGIA (joint pain) and PYREXIA (temperature of 100.8) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN for an unknown indication.   On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (chills). On 09-Mar-2021, the patient experienced FATIGUE (fatigue), ARTHRALGIA (joint pain) and PYREXIA (temperature of 100.8). At the time of the report, CHILLS (chills), FATIGUE (fatigue), ARTHRALGIA (joint pain) and PYREXIA (temperature of 100.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 (High) 100.8.         No treatment medications were reported.
Appendicitis - Started not feeling good a little before dinner time. Stomach pains I thought were IBS related. I fell asleep and kept waking up with stomach pains worsening. Around 12:45 AM on 04/29/2021 I drove myself to the Hospital and by around 3:30 AM I was told that I needed to have my appendix out. I did not have any symptoms prior to having the vaccine.  I was transferred to another Hospital to have surgery around 10 AM on 04/29/2021 to remove the appendix. The surgery was successful. I was sent home the morning of 04/30/2021.
Patient developed a red rash small red dots on arms and body-developed into large sores on body/arms-see pictures enclosed.  Prescriptions given for Bactroban ointment three times per day, Emycin 200/5 1 tsp twice daily for 10 days.
Within two hours of injection, I began to feel numbness in my right foot. Later that day, I experienced tingling in my fingers on both hands. This has continued for several days now and has worsened today (three days after injection), with the tingling being stronger and moving into my calves. I have had no loss of strength or coordination. I had similar peripheral neuropathy about 20 to 25 years ago; no reason was ever found, and it went away. This is the first recurrence in many years, and by far the most widespread on my body and the most acute sensations.
hives around his waist band and on both legs / was given prednisone; hives aggravated; This case was reported by a consumer via call center representative and described the occurrence of hives in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 11th October 2019, the patient received the 1st dose of Shingrix. On 23rd December 2019, the patient received the 2nd dose of Shingrix. In October 2019, immediately after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced hives. In December 2019, the patient experienced hives. The patient was treated with prednisone. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the hives and hives were unknown.   It was unknown if the reporter considered the hives to be related to Shingrix. It was unknown if the reporter considered the hives to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and shortly after receiving the vaccine he began to have hives around his waist band and on both legs. The patient went to see his HCP and was given prednisone.  The patient received Shingrix and since then the urticaria has began to worsen, spreading to his back, the corners of his eyes and around his mouth and was scheduled to see his HCP soon. The patient could not find HCP information for consent or follow up. The reporter did not consent to follow up. This case US2020AMR175939 is a duplicate of US2020175291. All future correspondence will be submitted to US2020175291.
no adverse effect reported; the patient received first dose of improperly stored VAQTA; This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported.  On 23-MAY-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) lot # R025518 (expiration date: 15-NOV-2019) first dose, intramuscularly for prophylaxis. No adverse effects were reported.
Pt developed pain at the injection site after 4 hr then pain in his right axilla, lateral chest area inferior to the axilla and right upper pectoralis/chest area with swelling and lymphadenopathy, tenderness to touch or with any arm movement.  Remains tender, swollen, lymph enlargement today
This is a spontaneous report from a non-contactable consumer (patient). A elderly male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, both doses Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single and on an unspecified date as dose 2, single both for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown whether COVID was diagnosed prior vaccination. It was reported that, on an unspecified date, patient had contracted COVID, after 4-5 months of receiving 2nd dose. Post vaccination, the patient had been tested for COVID-19. The outcome of the event was recovering.  No follow up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
This is a spontaneous report from a contactable nurse via Pfizer sales representative. A patient of an unspecified age, gender and race received PREVNAR 13 at single dose on unknown date for immunization. Medical history and concomitant medications were unknown. On unknown date the patient experienced rash for 5 days post vaccination. The outcome of the event was unknown.